Danyelza Injection
Product Images NDC 73042-201

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Danyelza (NDC 73042-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Y-mabs Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (40 mg/10 mL Vial Carton)

DANVELZA is an injection of naxitamab-gqgk in a single-dose vial. The vial contains 40mg/0mL (4mg/mL) of the drug. Unused portions of the medication should be discarded. The recommended dosage is not specified and the storage temperature should be between 2° to 8°C. The drug is produced by mAbs Therapeutics Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.